𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pretreatment prostate specific antigen (PSA) and 2-year PSA dynamics: Early predictors of prostate cancer prognosis with external radiation therapy

✍ Scribed by Chow, Po-Ming; Chiang, I-Ni; Cheng, Jason Chia-Hsien; Chiang, Bing-Juin; Pu, Yeong-Shiau; Huang, Chao-Yuan

Book ID
123540944
Publisher
Medknow Publications
Year
2013
Tongue
English
Weight
204 KB
Volume
24
Category
Article
ISSN
1879-5226

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pretreatment serum prostate-specific ant
Pretreatment serum prostate-specific antigen (PSA) level and PSA doubling times (PSADT) in black and white men with prostate cancer referred for radiation therapy
✍ W. Robert Lee; Gerald E. Hanks; Alexandra Hanlon; Timothy E. Schultheiss πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 438 KB πŸ‘ 1 views

Numerous racial differences have been reported for carcinoma of the prostate diagnosed in African-American (AA) men when compared to whites. These differences include: (1) a higher incidence in AA compared to whites, (2) a more advanced stage at diagnosis in A4, and (3) higher mortality rates in AA

Calculated prostate carcinoma volume : T
Calculated prostate carcinoma volume : The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter
✍ Anthony V. D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schu πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## Background: In this study, the authors evaluated whether a clinically relevant stratification of prostate specific antigen (psa) failure free survival (bned) after definitive local therapy could be made for patients with prostate carcinoma clinically classified as t1 or t2 and pretreatment psa l